Understanding how HbA1c levels predict pregnancy complications in women with gestational diabetes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to establish reference values for HbA1c that can predict adverse pregnancy outcomes in women diagnosed with gestational diabetes mellitus (GDM). It involves collecting data on HbA1c and fructosamine levels during antenatal care and documenting various pregnancy outcomes, including complications and modes of delivery. The study follows the NICE guidelines for diagnosing GDM and seeks to fill a knowledge gap regarding optimal HbA1c levels for managing this patient population. By analyzing these relationships, the study hopes to improve care for women with GDM.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Pregnant woman with singleton pregnancy
* Confirmed diagnosis of GDM based on Malaysia CPG (≥5.1/7.8)
* HbA1c level taken at least once at any time during the pregnancy
* Delivery after 28 weeks gestation

Exclusion Criteria:

* Major fetal anomaly
* Haemoglobin level of ≤9 g/dL (moderate or severe anaemia in pregnancy)
* Women with autoimmune diseases
* Overt diabetes or pre-existing diabetes

Where it's running

• Department of Obstetrics & Gynaecology, Hospital Canselor Tuanku Muhriz
  Cheras, Kuala Lumpur, Malaysia Recruiting

Study contacts

• Study coordinator: Rahana ARahman, MD
• Email: drrahana@ukm.edu.my
• Phone: +60391455964

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Early Glucose Patterns in Pregnant Women at Risk for GDM

  This study tests whether continuous glucose monitoring in early pregnancy can detect dysglycemia before GDM is diagnosed, in women with and without known risk factors.

  Recruiting DCB Research AG · Bern, Canton of Bern · NCT07783178

• Probiotic-augmented therapy for gestational diabetes

  This trial tests whether adding multistrain probiotics to metformin, insulin, or their combination can improve blood sugar control and inflammation in pregnant women with gestational diabetes.

  Recruiting Riphah International University · Rawalpindi, Punjab Province · NCT07645001

• Maternal insulin and fat metabolism in pregnancies at risk for preeclampsia and gestational diabetes

  This project will try to see if insulin resistance and how the body burns fats early in pregnancy predict later preeclampsia or gestational diabetes in people at higher risk.

  Recruiting University of Tennessee Graduate School of Medicine · Knoxville, Tennessee · NCT07565727

• How sleep, lifestyle, and metabolism relate to pregnancy outcomes in gestational diabetes

  This project will see if sleep quality, anxiety, eating and activity habits, and metabolic markers relate to blood sugar control and birth outcomes in pregnant people with gestational diabetes.

  Recruiting University of Split, School of Medicine · Split · NCT07314944

• Pre-eclampsia risk in pregnancies after oocyte donation

  We will follow pregnant women who used donated eggs and women who used their own eggs to see if pregnancies after oocyte donation lead to a higher risk of pre-eclampsia.

  Recruiting at 6 sites Copenhagen University Hospital, Hvidovre · Copenhagen and 5 other locations · NCT07263490

• Mobile-based obstetric monitoring for hypertension and diabetes during pregnancy

  A mobile app-based program lets pregnant people with high blood pressure or gestational diabetes track BP and glucose at home and share results with their care team to guide care.

  Recruiting at 3 sites Rutgers, The State University of New Jersey · Biratnagar and 2 other locations · NCT07243886

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.